Dr. Scott E. Eggener
Claim this profileUniversity of Chicago
Affiliated Hospitals
University Of Chicago
University Of Chicago Comprehensive Cancer Center
Clinical Trials Scott E. Eggener is currently running
Anti-inflammatory Drugs
for Elevated Prostate-Specific Antigen Levels
Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in \> 90% of cases. However, at the PSA levels which trigger prostate biopsy, often no cancer is found in prostate biopsy specimens. PSA test can be elevated due to reasons other than cancer such as inflammation or natural variation in the level. Investigators plan to treat men with elevated PSA level with over the counter anti-inflammatory medications (ibuprofen, naproxen) to see if the PSA level will decrease to an acceptable level.
Recruiting
3 awards
Phase 4
1 criteria
Urolithin A Supplementation
for Prostate Cancer
This phase II randomized control trial assesses the effect of Urolithin A (Uro-A) supplementation compared to placebo in men with biopsy-confirmed prostate cancer undergoing radical prostatectomy (RP) progressive disease. A total of 90 men will be accrued and randomized 1:1 to receive a 1000 mg daily dose of Uro-A in two 250 mg capsules PO BID or two placebo capsules BID daily for 3 to 6 weeks prior to RP. The primary endpoint is to determine the effect of Uro-A on decreasing prostate tumor tissue oxidative stress (measured by 8-OHdG) compared to placebo.
Recruiting
0 awards
Phase 2
More about Scott E. Eggener
Clinical Trial Related
5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Scott E. Eggener has experience with
- Ibuprofen
- Prostate MRI
- Ibuprofen Or Naproxen
- MRI-guided Transurethral Ultrasound Ablation
- Hemostatic Agent
- No Hemostatic Agent
Breakdown of trials Scott E. Eggener has run
Prostate Cancer
Prostate Specific Antigen Test
Prostate Cancer Screening
Prostate-Specific Antigen
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott E. Eggener specialize in?
Scott E. Eggener focuses on Prostate Cancer and Prostate Specific Antigen Test. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Scott E. Eggener currently recruiting for clinical trials?
Yes, Scott E. Eggener is currently recruiting for 5 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Scott E. Eggener has studied deeply?
Yes, Scott E. Eggener has studied treatments such as Ibuprofen, Prostate MRI, Ibuprofen or Naproxen.
What is the best way to schedule an appointment with Scott E. Eggener?
Apply for one of the trials that Scott E. Eggener is conducting.
What is the office address of Scott E. Eggener?
The office of Scott E. Eggener is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.